
Results
2
2 companies
MedinCell
Market Cap: €866.2m
Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.
MEDCL
€24.12
7D
-1.6%
1Y
33.9%
DBV Technologies
Market Cap: €738.0m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.49
7D
4.5%
1Y
43.2%